| No. of trial |
| Hypnotics | 22 | 2.9 |
Antianxiety | 38 | 5.1
| Psychiatric | 30 | 4.0
| Antidepressive | 23 | 3.1 |
Others(Nervus) | 20 | 2.7
| Cerebrovascular | 67 | 9.0
| Hypertension | 58 | 7.8
| Cardiac | 59 | 7.9
| Digestive tract | 45 | 6.0
| Respiratory | 37 | 5.0
| Hyperlipidemia | 25 | 3.4
| Diabetes | 12 | 1.6
| Hepatic Disease | 18 | 2.4
| Renal Disease | 24 | 3.2
| Osteoporosis | 16 | 2.1
| NSAID | 68 | 9.1
| Urogenital | 29 | 3.9
| Dermatology | 24 | 3.2
| Ophalmology | 24 | 3.2
| Antibiotics | 42 | 5.6 |
Neoplastic Disease | 7 | 0.9
| Others | 58 | 7.8
| |
|---|
| Long term trial | 21
| PMS(Surbey on Clinical Use et al) | 4
| | ||